Javascript must be enabled to continue!
Risk Factors of Rebound Hyperbilirubinemia in Post Phototherapy Hyperbilirubinemia Infants
View through CrossRef
Background: Post phototherapy rebound hyperbilirubinemia is a cause for readmission in some infants.However, this phenomenon data of rebound hyperbilirubinemia is lacking from Indonesia. Our study aimsto describe the risk factor of post phototherapy rebound hyperbilirubinemia in the infant.Method: Cross-sectional study of all infants with indirect hyperbilirubinemia who were treated phototherapyaccording to standard guidelines in neonate intermediate unit Dr. Soetomo hospital for 6 months from June2017 until December 2017. Bilirubin was measured 24 hours after phototherapy. Bilirubin rebound isconsidered as increasing total serum bilirubin that needs reinstitution of phototherapy.Result: A total of 53 (44.9%) infants developed rebound hyperbilirubinemia. We revealed the following riskfactor for rebound hyperbilirubinemia was the onset of jaundice on < 3 days, (10 babies, p <0.05). Otherresults are 30 (56.6%) female infants, 39 (73%) birth weight < 2500 g, 36 (67%) infants with a history ofcesarean section, and 38 (71%) preterm infants but there are not statistically significant.Conclusion: Post phototherapy rebound hyperbilirubinemia should be considered in the onset of jaundice< 3 days.
Institute of Medico-legal Publications Private Limited
Title: Risk Factors of Rebound Hyperbilirubinemia in Post Phototherapy Hyperbilirubinemia Infants
Description:
Background: Post phototherapy rebound hyperbilirubinemia is a cause for readmission in some infants.
However, this phenomenon data of rebound hyperbilirubinemia is lacking from Indonesia.
Our study aimsto describe the risk factor of post phototherapy rebound hyperbilirubinemia in the infant.
Method: Cross-sectional study of all infants with indirect hyperbilirubinemia who were treated phototherapyaccording to standard guidelines in neonate intermediate unit Dr.
Soetomo hospital for 6 months from June2017 until December 2017.
Bilirubin was measured 24 hours after phototherapy.
Bilirubin rebound isconsidered as increasing total serum bilirubin that needs reinstitution of phototherapy.
Result: A total of 53 (44.
9%) infants developed rebound hyperbilirubinemia.
We revealed the following riskfactor for rebound hyperbilirubinemia was the onset of jaundice on < 3 days, (10 babies, p <0.
05).
Otherresults are 30 (56.
6%) female infants, 39 (73%) birth weight < 2500 g, 36 (67%) infants with a history ofcesarean section, and 38 (71%) preterm infants but there are not statistically significant.
Conclusion: Post phototherapy rebound hyperbilirubinemia should be considered in the onset of jaundice< 3 days.
Related Results
Cylindrical intensive vs. double surface LED phototherapy for neonatal hyperbilirubinemia
Cylindrical intensive vs. double surface LED phototherapy for neonatal hyperbilirubinemia
Background High bilirubin levels may lead to complications such as bilirubin encephalopathy or even death. Therefore, neonatal hyperbilirubinemia patients require appropriate treat...
A study on effect of phototherapy on platelet count in neonates with unconjugated hyperbilirubinemia: a hospital based prospective observational study
A study on effect of phototherapy on platelet count in neonates with unconjugated hyperbilirubinemia: a hospital based prospective observational study
Background: Thrombocytopenia as a side effect of phototherapy has not been mentioned in standard literature and textbooks. Though there are few studies in this regard, but results ...
19 Treatment of Neonatal Hyperbilirubinemia – Ontario Cohort 2014-2018
19 Treatment of Neonatal Hyperbilirubinemia – Ontario Cohort 2014-2018
Abstract
Background
Serious complications that could result from severe neonatal hyperbilirubinemia include acute and chronic bi...
Double versus Single Phototherapy in the Treatment of Neonatal Hyperbilirubinemia
Double versus Single Phototherapy in the Treatment of Neonatal Hyperbilirubinemia
Background: Hyperbilirubinemia is a common problem in full-term newborns. Since the 1950s, phototherapy has been the choice of treatment for lowering bilirubin concentration in neo...
Comparison of phototherapy with ursodeoxycholic acid versus phototherapy alone in neonates with hyperbilirubinemia alone.
Comparison of phototherapy with ursodeoxycholic acid versus phototherapy alone in neonates with hyperbilirubinemia alone.
Objective: To compare the mean duration of phototherapy in neonates with indirect hyperbilirubinemia undergoing phototherapy with ursodeoxycholic acid versus phototherapy alone. St...
Effect of phototherapy on platelet count in neonates with unconjugated hyperbilirubinemia
Effect of phototherapy on platelet count in neonates with unconjugated hyperbilirubinemia
Background: Hyperbilirubinemia in newborn is quite common. Phototherapy (PT) is one of the most common noninvasive methods for the treatment of this hyperbilirubinemia. There are l...
Comparison of Intermittent vs. Continuous Phototherapy in the treatment of Non-Haemolytic Neonatal Hyperbilirubinemia
Comparison of Intermittent vs. Continuous Phototherapy in the treatment of Non-Haemolytic Neonatal Hyperbilirubinemia
Introduction: Phototherapy is used in the treatment of hyperbilirubinemia in initial life-span of neonates. Our objective was the comparison of continuous vs intermittent photother...
EFFECT OF PHOTOTHERAPY ON SERUM ELECTROLYTESIN NEONATES ≥35 WEEKS OF GESTATION WITH HYPERBILIRUBINEMIA
EFFECT OF PHOTOTHERAPY ON SERUM ELECTROLYTESIN NEONATES ≥35 WEEKS OF GESTATION WITH HYPERBILIRUBINEMIA
Background:Neonatal hyperbilirubinemia is common (≈60% of term and 85% of preterm infants) and can lead to neurotoxicity or kernicterus if untreated. Phototherapy is the s...

